Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms
- PMID: 9460791
- DOI: 10.1016/s0301-0082(97)00053-1
Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms
Abstract
Dementia due to human immunodeficiency virus (HIV) infection is the commonest cause of dementia in children, young adults and middle-aged people. Its incidence continues to rise despite the use of newer antiretroviral agents. The study of the pathogenesis of HIV dementia has lead to the discovery of novel mechanisms of neural dysfunction and toxicity, and holds promise for further discovery of new molecules and pathways involved in maintaining cerebral function and enabling dysfunction. New to the field of neurovirology is the emerging concept that proteins that are part of the virus may themselves be neurotoxic by virtue of their abilities to be either directly toxic to brain cells or may, through their actions on glial cells or macrophages, release neurotoxic products coded by the host genome. These mechanisms have been demonstrated for HIV-1 and accordingly we propose a new term, virotoxins, to describe such actions. This review provides an in-depth analysis of the pathophysiological mechanisms by which these viral and cellular products affected by HIV virotoxins cause neural dysfunction.
Similar articles
-
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.J Infect Dis. 2002 Dec 1;186 Suppl 2:S193-8. doi: 10.1086/344528. J Infect Dis. 2002. PMID: 12424697 Review.
-
Pathobiology of human immunodeficiency virus dementia.Semin Neurol. 1999;19(2):113-27. doi: 10.1055/s-2008-1040830. Semin Neurol. 1999. PMID: 10718533 Review.
-
[Dementia and human inmmunodeficiency virus infection].Rev Neurol (Paris). 1998;154 Suppl 2:S91-8. Rev Neurol (Paris). 1998. PMID: 9834549 Review. French.
-
Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.Neurosci Biobehav Rev. 2008 Jul;32(5):883-909. doi: 10.1016/j.neubiorev.2008.01.004. Epub 2008 Mar 18. Neurosci Biobehav Rev. 2008. PMID: 18430470 Free PMC article. Review.
-
Macrophages, chemokines and neuronal injury in HIV-1-associated dementia.Cell Mol Biol (Noisy-le-grand). 2002 Mar;48(2):137-50. Cell Mol Biol (Noisy-le-grand). 2002. PMID: 11995633 Review.
Cited by
-
Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions.Neurochem Res. 2004 May;29(5):965-78. doi: 10.1023/b:nere.0000021241.90133.89. Neurochem Res. 2004. PMID: 15139295 Review.
-
Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD).Mol Neurodegener. 2011 Jan 11;6(1):3. doi: 10.1186/1750-1326-6-3. Mol Neurodegener. 2011. PMID: 21223591 Free PMC article.
-
HIV-1-Tat excites cardiac parasympathetic neurons of nucleus ambiguus and triggers prolonged bradycardia in conscious rats.Am J Physiol Regul Integr Comp Physiol. 2014 Jun 1;306(11):R814-22. doi: 10.1152/ajpregu.00529.2013. Epub 2014 Apr 2. Am J Physiol Regul Integr Comp Physiol. 2014. PMID: 24694382 Free PMC article.
-
Neuroimmune basis of methamphetamine toxicity.Int Rev Neurobiol. 2014;118:165-97. doi: 10.1016/B978-0-12-801284-0.00007-5. Int Rev Neurobiol. 2014. PMID: 25175865 Free PMC article. Review.
-
Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Int Rev Neurobiol. 2014;118:231-313. doi: 10.1016/B978-0-12-801284-0.00009-9. Int Rev Neurobiol. 2014. PMID: 25175867 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
